Table 1 Clinical characteristics of patients with and without DM
From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
DM | |||
|---|---|---|---|
Yes (n = 700) | No (n = 1458) | P value | |
Age | 72.3 ± 10.0 | 69.2 ± 12.7 | < 0.001 |
Age ≥ 80 (%) | 24.9 | 21.4 | 0.078 |
Female gender (%) | 34.9 | 39.9 | 0.066 |
Hypertension (%) | 82.9 | 59.8 | < 0.001 |
Hypercholesterolemia (%) | 71.0 | 47.9 | < 0.001 |
Smoking (%) | 30.8 | 29.3 | 0.483 |
Chronic renal failure (%) | 13.2 | 7.5 | < 0.001 |
Peripheral artery disease (%) | 14.2 | 9.0 | < 0.001 |
Previous CAD (%) | 41.7 | 27.4 | < 0.001 |
Previous infarction (%) | 17.9 | 11.4 | < 0.001 |
Previous PCI (%) | 23.6 | 15.5 | < 0.001 |
Previous CABG (%) | 6.7 | 3.4 | 0.001 |
Previous valve replacement (%) | 3.5 | 4.9 | 0.144 |
Left ventricular dysfunction (%) | 27.1 | 21.4 | 0.033 |
NYHA > II (%) | 20.1 | 19.0 | 0.282 |
CCS > II (%) | 10.0 | 8.4 | 0.001 |
Main cardiovascular condition (%) | |||
Ischemic heart disease | 57.6 | 47.0 | < 0.001 |
Valvular heart disease | 29.2 | 36.9 | |
Other | 13.3 | 16.2 | |